Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Pathology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 17717150PMCID PMC1988877
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit.

  2007cited by this paper
• TWEAK—Fn14 Pathway Inhibition Protects the Integrity of the Neurovascular Unit during Cerebral Ischemia

  2007cited by this paper
• Regulation of the Composition of the Extracellular Matrix by Low Density Lipoprotein Receptor-related Protein-1

  2006cited by this paper
• Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice

  2006cited by this paper
• Tissue-type Plasminogen Activator Acts as a Cytokine That Triggers Intracellular Signal Transduction and Induces Matrix Metalloproteinase-9 Gene Expression*

  2006cited by this paper
• Oxygen Glucose Deprivation Switches the Transport of tPA Across the Blood–Brain Barrier From an LRP-Dependent to an Increased LRP-Independent Process

  2005cited by this paper
• Glial nitric oxide and ischemia

  2005cited by this paper
• Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia.

  2005cited by this paper
• Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner.

  2005cited by this paper
• Tissue-Type Plasminogen Activator Crosses the Intact Blood-Brain Barrier by Low-Density Lipoprotein Receptor–Related Protein-Mediated Transcytosis

  2005cited by this paper
• Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Increases the Permeability of the Neurovascular Unit through Nuclear Factor-κB Pathway Activation

  2005cited by this paper
• Shaping the nuclear action of NF-kappaB.

  2004cited by this paper
• Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer.

  2004cited by this paper
• LDL and HDL affect nitric oxide metabolism in human astrocytoma cells.

  2004cited by this paper
• Cerebral Microvessel Responses to Focal Ischemia

  2003cited by this paper
• Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.

  2003cited by this paper
• Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator

  2003cited by this paper
• Absence of Tissue Plasminogen Activator Gene or Activity Impairs Mouse Cerebellar Motor Learning

  2003cited by this paper
• LRP: Role in Vascular Wall Integrity and Protection from Atherosclerosis

  2003cited by this paper
• Progressive Ankylosis (Ank) Protein Is Expressed by Neurons and Ank Immunohistochemical Reactivity Is Increased by Limbic Seizures

  2003cited by this paper
• Neutrophils do not contribute to infarction, oxidative stress, and NO synthase activity in severe brain ischemia.

  2003cited by this paper
• Inducible nitric oxide synthase expression in the ischemic core and penumbra after transient focal cerebral ischemia in mice.

  2002cited by this paper
• Binding of Urokinase to Low Density Lipoprotein-related Receptor (LRP) Regulates Vascular Smooth Muscle Cell Contraction*

  2002cited by this paper
• Recombinant adenoviral expression of dominant negative IkappaBalpha protects brain from cerebral ischemic injury.

  2002cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• NF-kappaB in neuronal plasticity and neurodegenerative disorders.

  2001cited by this paper
• LRP: a multifunctional scavenger and signaling receptor.

  2001cited by this paper
• The LDL receptor gene family: (un)expected signal transducers in the brain.

  2001cited by this paper
• Cerebral ischemia and inflammation

  2001cited by this paper
• Neuroserpin, a neuroprotective factor in focal ischemic stroke.

  2001cited by this paper
• Roles of nuclear factor kappaB in neuronal survival and plasticity.

  2000cited by this paper
• The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors.

  2000cited by this paper
• Role of Tissue Plasminogen Activator Receptor LRP in Hippocampal Long-Term Potentiation

  2000cited by this paper
• Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis.

  2000cited by this paper
• Transcription Factor Nuclear Factor-Kappa B is Activated in Neurons after Focal Cerebral Ischemia

  2000cited by this paper
• NF-kappaB is activated and promotes cell death in focal cerebral ischemia.

  1999cited by this paper
• Bradykinin Induces Interleukin‐6 Expression in Astrocytes Through Activation of Nuclear Factor‐κB

  1999cited by this paper
• Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.

  1999cited by this paper
• In utero gene therapy: The case for

  1999cited by this paper
• Pathobiology of ischaemic stroke: an integrated view.

  1999cited by this paper
• Expression of hepatocyte low-density lipoprotein receptor-related protein is post-transcriptionally regulated by extracellular matrix.

  1998cited by this paper
• Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice

  1998cited by this paper
• Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene

  1997cited by this paper
• Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin.

  1997cited by this paper
• Activated astrocytes induce nitric oxide synthase‐2 in cerebral endothelium via tumor necrosis factor α

  1997cited by this paper
• An Extracellular Proteolytic Cascade Promotes Neuronal Degeneration in the Mouse Hippocampus

  1997cited by this paper
• Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation.

  1996cited by this paper
• Localisation of NADPH diaphorase activity and NOS immunoreactivity in astroglia in normal adult rat brain.

  1996cited by this paper
• Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency.

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Tissue Plasminogen Activator Induction in Purkinje Neurons After Cerebellar Motor Learning

  1995cited by this paper
• Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator

  1995cited by this paper
• Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.

  1994cited by this paper
• Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor.

  1992cited by this paper
• Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death.

  1992cited by this paper
• Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator.

  1992cited by this paper
• Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain.

  1992cited by this paper
• Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor.

  1990cited by this paper
• Evidence for an Astrocyte‐Derived Vasorelaxing Factor with Properties Similar to Nitric Oxide

  1990cited by this paper
• Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins.

  1989cited by this paper
• Tissue plasminogen activator reduces neurological damage after cerebral embolism.

  1985cited by this paper
• Plasminogen activator release at the neuronal growth cone.

  1981cited by this paper
• Plasminogen activator secretion by granule neurons in cultures of developing cerebellum.

  1981cited by this paper

• Effects of blood pressure lowering in patients treated with intravenous thrombolysis before endovascular thrombectomy

  2025cites this paper
• Plasma protein signatures associated with functional outcome heterogeneity in rtPA-treated acute ischemic stroke.

  2025cites this paper
• Tissue Plasminogen Activator as an Approved Strategy for Ischemic Stroke: A Review of tPA’s Structure, Mechanism of Action and the Novel Targeting Methods

  2025cites this paper
• The blood–brain barrier: a help and a hindrance

  2025cites this paper
• Construction of an lncRNA-mediated ceRNA network to investigate the inflammatory regulatory mechanisms of ischemic stroke

  2025cites this paper
• The Effect of Low-Density Lipoprotein Receptor-Related Protein-1 on Acute Kidney Injury and Renal Tubular Epithelial Triglyceride Accumulation

  2025cites this paper
• The role and therapeutic potential of nuclear factor κB (NF-κB) in ischemic stroke.

  2024cites this paper
• Glutathione S-transferase: A keystone in Parkinson's disease pathogenesis and therapy.

  2024cites this paper
• A promising frontier: targeting NETs for stroke treatment breakthroughs

  2024cites this paper
• Macrophage Function Modulated by tPA Signaling in Mouse Experimental Kidney Disease Models

  2023cites this paper
• CD44s-activated tPA/LRP1-NFκB pathway drives lamellipodia outgrowth in luminal-type breast cancer cells

  2023cites this paper
• NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases

  2022cites this paper
• Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage

  2021cites this paper
• Plasminogen Activators in Neurovascular and Neurodegenerative Disorders

  2021cites this paper
• Tissue-type plasminogen activator induces TNF-α-mediated preconditioning of the blood-brain barrier

  2021cites this paper
• From the low-density lipoprotein receptor–related protein 1 to neuropathic pain: a potentially novel target

  2021cites this paper
• NF-κB and tPA Signaling in Kidney and Other Diseases

  2020influential citation
• Prothymosin alpha and its mimetic hexapeptide improve delayed tissue plasminogen activator‐induced brain damage following cerebral ischemia

  2020cites this paper
• The multifaceted role of plasminogen in inflammation

  2020cites this paper
• Post-stroke neuronal circuits and mental illnesses.

  2019cites this paper
• Low Density Receptor-Related Protein 1 Interactions With the Extracellular Matrix: More Than Meets the Eye

  2019cites this paper
• The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer’s Disease (PS1V97L)

  2018cites this paper
• Numerous Fasciola plasminogen-binding proteins may underlie blood-brain barrier leakage and explain neurological disorder complexity and heterogeneity in the acute and chronic phases of human fascioliasis

  2018cites this paper
• Activation of cell surface GRP78 decreases endoplasmic reticulum stress and neuronal death

  2017cites this paper
• Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology

  2017cites this paper
• One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke

  2017cites this paper
• Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an in vitro model of ischemic stroke

  2017cites this paper
• Curcumin by down-regulating NF-kB and elevating Nrf2, reduces brain edema and neurological dysfunction after cerebral I/R.

  2016cites this paper
• Cancer therapy targeting the fibrinolytic system.

  2016cites this paper
• Tissue-type Plasminogen Activator (tPA) Modulates the Postsynaptic Response of Cerebral Cortical Neurons to the Presynaptic Release of Glutamate

  2016cites this paper
• Preparation of Angiopep-2 Peptide-Modified Bubble Liposomes for Delivery to the Brain.

  2016cites this paper
• Epsilon Aminocaproic Acid Pretreatment Provides Neuroprotection Following Surgically Induced Brain Injury in a Rat Model.

  2016cites this paper
• Implication du remodelage de l'unité neurovasculaire dans la maladie d'Alzheimer : l'hypoperfusion cérébrale et le système de l'activateur tissulaire du plasminogène

  2016cites this paper
• The plasminogen activation system in neuroinflammation.

  2016cites this paper
• Tissue-type plasminogen activator is a neuroprotectant in the central nervous system

  2015cites this paper
• Anti‐tissue Plasminogen Activator (tPA) as an Effective Therapy of Neonatal Hypoxia–Ischemia with and without Inflammation

  2015cites this paper
• Understanding the Functions of Endogenous and Exogenous Tissue-Type Plasminogen Activator During Stroke

  2015cites this paper
• Tissue-Type Plasminogen Activator Triggers the Synaptic Vesicle Cycle in Cerebral Cortical Neurons

  2015cites this paper
• Recombinant tissue plasminogen activator promotes, and progesterone attenuates, microglia/macrophage M1 polarization and recruitment of microglia after MCAO stroke in rats.

  2015cites this paper
• Tissue plasminogen activator and inflammation: from phenotype to signaling mechanisms.

  2014influential citation
• Tissue Plasminogen Activator: Side Effects and Signaling.

  2014cites this paper
• Recombinant Tissue Plasminogen Activator Enhances Microglial Cell Recruitment after Stroke in Mice

  2014cites this paper
• Les neurones pyramidaux corticaux dans le couplage neurovasculaire et neurométabolique : mécanismes cellulaires et moléculaires

  2014cites this paper
• Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes.

  2014cites this paper
• Toona sinensis Inhibits LPS-Induced Inflammation and Migration in Vascular Smooth Muscle Cells via Suppression of Reactive Oxygen Species and NF-κB Signaling Pathway

  2014cites this paper
• Tissue Plasminogen Activator Promotes Postischemic Neutrophil Recruitment via Its Proteolytic and Nonproteolytic Properties

  2014cites this paper
• LRP-1: Functions, Signaling and Implications in Kidney and Other Diseases

  2014cites this paper
• Plasminogen activator inhibitor-1 mitigates brain injury in a rat model of infection-sensitized neonatal hypoxia-ischemia.

  2013cites this paper
• Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke

  2013cites this paper
• Tissue-type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK1/2-CREB-ATF3 signaling pathway.

  2013cites this paper
• Tissue-Type Plasminogen Activator Mediates Neuronal Detection and Adaptation to Metabolic Stress

  2013cites this paper
• Alteplase

  2012cites this paper
• Endothelial Cells and Astrocytes: A Concerto en Duo in Ischemic Pathophysiology

  2012cites this paper
• La barrière hémato-encéphalique lors de l’ischémie cérébrale : une cible thérapeutique

  2012cites this paper
• The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans.

  2012cites this paper
• [Dysfunction of the blood-brain barrier during ischaemia: a therapeutic concern].

  2012cites this paper
• tPA in the injured central nervous system: different scenarios starring the same actor?

  2012cites this paper
• Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase.

  2012cites this paper
• Phosphatidylinositol-3-Kinase Gamma Plays a Central Role in Blood–Brain Barrier Dysfunction in Acute Experimental Stroke

  2011cites this paper
• Depletion of tissue plasminogen activator attenuates lung ischemia-reperfusion injury via inhibition of neutrophil extravasation.

  2011cites this paper
• Olfactory ensheathing cells moderate nuclear factor kappaB translocation in astrocytes.

  2011cites this paper
• Recombinant tissue plasminogen activator induces blood–brain barrier breakdown by a matrix metalloproteinase‐9‐independent pathway after transient focal cerebral ischemia in mouse

  2011cites this paper
• Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: intracranial bleeding associated with the treatment of ischemic stroke: thrombolytic treatment of ischemia-affected endothelial cells with tissue-type plasminogen activator.

  2011cites this paper
• Interaction of olfactory ensheathing cells with other cell types in vitro and after transplantation: glial scars and inflammation.

  2011cites this paper
• Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator.

  2010cites this paper
• Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.

  2010cites this paper
• Tissue‐type plasminogen activator induces plasmin‐dependent proteolysis of intracellular neuronal nitric oxide synthase

  2010cites this paper
• LDL receptor-related protein 1 regulates the abundance of diverse cell-signaling proteins in the plasma membrane proteome.

  2010cites this paper
• Low Density Lipoprotein Receptor-related Protein (LRP1) Regulates Rac1 and RhoA Reciprocally to Control Schwann Cell Adhesion and Migration*

  2010cites this paper
• Roles of fibrinolytic system components in the nervous system.

  2010cites this paper
• Cardiovascular , Pulmonary and Renal Pathology tPA Activates LDL Receptor-Related Protein 1-Mediated Mitogenic Signaling Involving the p 90 RSK and GSK 3 Pathway

  2010cites this paper
• The Contribution of L-Arginine to the Neurotoxicity of Recombinant Tissue Plasminogen Activator following Cerebral Ischemia: A Review of rtPA Neurotoxicity

  2010cites this paper
• Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.

  2010cites this paper
• Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition.

  2010cites this paper
• NF-κΒ Signaling in Neurite Growth and Neuronal Survival

  2010cites this paper
• Role of tissue-type plasminogen activator in ischemic stroke.

  2010cites this paper
• tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3beta pathway.

  2010cites this paper
• NF-kappaB signaling in cerebral ischemia.

  2009cites this paper
• Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation.

  2009cites this paper
• Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.

  2009cites this paper
• Tissue plasminogen activator‐mediated PDGF signaling and neurovascular coupling in stroke

  2009cites this paper
• The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain.

  2009cites this paper
• Microglial LRP1 modulates JNK activation: A signaling cascade that also regulates apolipoprotein E levels

  2009influential citation
• Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein.

  2009cites this paper
• Can RAP save your brain?

  2009cites this paper
• Norrin attenuates protease-mediated death of transformed retinal ganglion cells

  2009cites this paper
• Microglial Low-Density Lipoprotein Receptor-Related Protein 1 Mediates the Effect of Tissue-Type Plasminogen Activator on Matrix Metalloproteinase-9 Activity in the Ischemic Brain

  2009cites this paper
• Regulation of tumor necrosis factor receptor-1 and the IKK-NF-kappaB pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor.

  2008cites this paper
• Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain.

  2008cites this paper
• Haemopexin affects iron distribution and ferritin expression in mouse brain

  2008cites this paper
• UNIVERSITY OF FLORIDA THESIS OR DISSERTATION FORMATTING TEMPLATE

  2008cites this paper
• Regulated intramembrane proteolysis of the low-density lipoprotein receptor-related protein mediates ischemic cell death.

  2008cites this paper